Skip to main content

Lynx1 Capital Management LP

Position in STOK — Stoke Therapeutics, Inc.

CIK 1910456 DORADO, PR

Position in STOK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$132,136,578
-$22,968,614 QoQ
Shares Held
4,038,404
-15.2% QoQ
Ownership
6.26%
of shares outstanding
% of Portfolio
15.27%
of 13F equity value
Holder Rank
#4
of 194 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in STOK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lynx1 Capital Management LP holds $865,408,538 across 26 Biotechnology names. STOK ranks #3 (15.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 STOK
Stoke Therapeutics, Inc.
This page
4,038,404 $132,136,578

All Filings in STOK

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $132,136,578 4,038,404
2026-06-30 $132,136,578 4,038,404
2026-03-31 $155,105,192 4,763,673
2025-12-31 $171,544,352 5,404,674
2025-09-30 $127,009,839 5,404,674
2025-06-30 $61,343,049 5,404,674
2025-03-31 $35,191,327 5,291,929
2024-12-31 $57,214,716 5,187,191
2024-09-30 $63,750,577 5,187,191
2024-06-30 $70,051,930 5,185,191
2024-03-31 $49,907,070 3,696,820
2023-12-31 $15,553,388 2,956,918
2023-09-30 $6,738,006 1,710,154